| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11008459 | International Journal of Antimicrobial Agents | 2018 | 27 Pages |
Abstract
No differences in clinical outcomes were observed between carbapenems and non-carbapenem β-lactams in nosocomial pneumonias. Those infected with P. aeruginosa fared worse and were more likely to have resistance develop if they were treated with imipenem. Additional studies are warranted.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
J Nicholas (Assistant Professor of Pharmacy Practice), Nathaniel J (Assistant Professor of Pharmacy Practice), Jenna (Clinical Pharmacist), Rebecca PharmD, Marc H (Professor of Pharmacy Practice),